{
    "ticker": "SIM",
    "name": "Simulations Plus, Inc.",
    "description": "Simulations Plus, Inc. is a leading provider of simulation and modeling software for the pharmaceutical and biotechnology industries. Founded in 1996, the company leverages its proprietary technologies to improve the drug development process, making it more efficient and cost-effective. Simulations Plus offers a range of software products, including GastroPlus, which models the absorption, distribution, metabolism, and excretion (ADME) of drugs; ADMET Predictor, used for predicting ADMET properties; and DDDPlus, which assists in the development of drug formulations. The company's innovative tools help researchers and scientists make informed decisions throughout the drug development lifecycle, leading to faster and more successful outcomes. With a focus on scientific rigor and user-friendly interfaces, Simulations Plus is committed to advancing the field of predictive pharmacokinetics and pharmacodynamics. The company also provides consulting services to assist clients in utilizing its software effectively. By combining advanced technology with expert support, Simulations Plus continues to be at the forefront of pharmaceutical research and development, striving to enhance the efficiency of drug discovery and approval processes.",
    "industry": [
        "Software",
        "Pharmaceuticals"
    ],
    "headquarters": "Lancaster, California, USA",
    "founded": "1996",
    "website": "https://www.simulations-plus.com",
    "ceo": "Walt Woltosz",
    "social_media": {
        "twitter": "https://twitter.com/SimulationsPlus",
        "linkedin": "https://www.linkedin.com/company/simulations-plus/"
    },
    "investor_relations": "https://www.simulations-plus.com/investor-relations/",
    "key_executives": [
        {
            "name": "Walt Woltosz",
            "position": "CEO"
        },
        {
            "name": "John D. McCulloch",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Software Products",
            "products": [
                "GastroPlus",
                "ADMET Predictor",
                "DDDPlus"
            ]
        },
        {
            "category": "Consulting Services",
            "products": [
                "Custom Software Solutions",
                "Training and Support"
            ]
        }
    ],
    "seo": {
        "meta_title": "Simulations Plus, Inc. | Pharmaceutical Simulation and Modeling Software",
        "meta_description": "Explore Simulations Plus, Inc., a leader in simulation and modeling software for the pharmaceutical industry. Discover innovative solutions for drug development.",
        "keywords": [
            "Simulations Plus",
            "Pharmaceutical Software",
            "Drug Development",
            "GastroPlus",
            "ADMET Predictor",
            "Modeling Software"
        ]
    },
    "faq": [
        {
            "question": "What does Simulations Plus do?",
            "answer": "Simulations Plus provides simulation and modeling software for the pharmaceutical and biotechnology industries to improve drug development."
        },
        {
            "question": "Who is the CEO of Simulations Plus?",
            "answer": "Walt Woltosz is the CEO of Simulations Plus, Inc."
        },
        {
            "question": "Where is Simulations Plus headquartered?",
            "answer": "Simulations Plus is headquartered in Lancaster, California, USA."
        },
        {
            "question": "What are the main software products offered by Simulations Plus?",
            "answer": "The main software products include GastroPlus, ADMET Predictor, and DDDPlus."
        },
        {
            "question": "When was Simulations Plus founded?",
            "answer": "Simulations Plus was founded in 1996."
        }
    ],
    "competitors": [
        "PKG",
        "RGEN",
        "VRNA"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "BIIB",
        "CELG"
    ]
}